Five cancer drugs back on NHS list after deals with drug companiesBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5985 (Published 06 November 2015) Cite this as: BMJ 2015;351:h5985
- Nigel Hawkes
Five cancer drugs have been reinstated on the list paid for by England’s Cancer Drugs Fund, after manufacturers provided discounts to make them more affordable.
The fund faces rising costs, and in September it announced the removal of 16 drugs used in 23 treatments, in an attempt to balance its books.1 Thanks to the new deal it has now been able to reinstate five, used in seven treatments, reducing the number of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial